Abbott Laboratories

Pharmaceuticals
United States
Executive 1Mr. Miles D. White, Chairman; Chief Executive Officer | Chairman; Chief Executive Officer
Executive 2Mr. Thomas C. Freyman, Executive Vice President; | Deputy Chief Executive;
Earnings Per Share Growth (%)-8.02%
Cost of Goods Sold (US$ Millions)$9,218
Current Liabilities (US$ Millions)$10,532
Total Assets (US$ Millions)$15,261
Long Term Debt (Millions)$3,408
Return on Equity9.07%
Revenue (US$ Millions)$20,247
Total Company Assets$41,275
Revenue Growth (%)-7.33%
Net Income (US$ Millions)$2,284
Earnings Per Share (US$)$1.49
Total Equity (US$ Millions)$21,526
Profit Margin (%)11.28%
Debt To Equity Ratio (%)0.16%
Inventories (Millions)$2,643